9/28/2021
|
The Mid-South Miracle: A Program-Based Approach to Reducing Population-Level Lung Cancer Mortality |
Raymond Osarogiagbon, M.D. |
https://cpfp.cancer.gov |
9/14/2021
|
Healthy Living After Cancer: Translating What We Know into What We Do |
Karen Basen-Engquist, Ph.D., M.P.H. |
https://cpfp.cancer.gov |
6/15/2021
|
Beyond a Closed-Ended Question: Understanding the Decision to Screen or Not for Lung Cancer |
Lisa Carter-Harris, Ph.D. |
https://cpfp.cancer.gov |
5/11/2021
|
From Spaceflight to Cancer Therapy: The Next Frontier of Multisystem Toxicity Countermeasures |
Jessica Scott, Ph.D. |
https://cpfp.cancer.gov |
5/04/2021
|
Building Bridges to Enhance Cancer Prevention and Care |
Ashwani Rajput, M.D. |
https://cpfp.cancer.gov |
5/04/2021
|
Early Detection Research Network (EDRN): A National Program for Cancer Biomarker Development |
Sudhir Srivastava, Ph.D., M.P.H. |
https://prevention.cancer.gov |
4/26/2021
|
Cancer Prevention and Interception Targeted Agent Discovery Program (CAP-IT) |
Shizuko Sei, M.D. |
https://prevention.cancer.gov |
4/26/2021
|
Cancer Prevention and Screening: Progress Made and Progress to Come |
Doug Lowy, M.D., John Schiller, Ph.D., Brandy Heckman-Stoddard, Ph.D., M.P.H., Lisa Richardson, M.D., M.P.H. |
https://prevention.cancer.gov |
4/20/2021
|
Polygenic Risk Scores in Cancer Prevention |
Nilanjan Chatterjee, Ph.D. |
https://cpfp.cancer.gov |
4/06/2021
|
HPV Vaccine Strategies in the US: Why Haven’t We Been More Successful? |
Ellen M. Daley, Ph.D., M.P.H. |
https://cpfp.cancer.gov |